These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28442738)

  • 1. Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion.
    Sciortino M; Camacho-Leal MDP; Orso F; Grassi E; Costamagna A; Provero P; Tam W; Turco E; Defilippi P; Taverna D; Cabodi S
    Sci Rep; 2017 Apr; 7(1):1145. PubMed ID: 28442738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1.
    Tornillo G; Bisaro B; Camacho-Leal Mdel P; Galiè M; Provero P; Di Stefano P; Turco E; Defilippi P; Cabodi S
    Eur J Cell Biol; 2011; 90(2-3):237-48. PubMed ID: 20961652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells.
    Pincini A; Tornillo G; Orso F; Sciortino M; Bisaro B; Leal Mdel P; Lembo A; Brizzi MF; Turco E; De Pittà C; Provero P; Medico E; Defilippi P; Taverna D; Cabodi S
    Cell Cycle; 2013 Aug; 12(15):2409-22. PubMed ID: 23839042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.
    Bisaro B; Sciortino M; Colombo S; Camacho Leal MP; Costamagna A; Castellano I; Montemurro F; Rossi V; Valabrega G; Turco E; Defilippi P; Cabodi S
    Oncotarget; 2016 Jan; 7(4):4442-53. PubMed ID: 26716506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
    Costamagna A; Rossi Sebastiano M; Natalini D; Simoni M; Valabrega G; Defilippi P; Visentin S; Ermondi G; Turco E; Caron G; Cabodi S
    Sci Rep; 2019 Feb; 9(1):3089. PubMed ID: 30816273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
    Peng M; Ball-Kell SM; Tyner AL
    Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p130Cas is an essential transducer element in ErbB2 transformation.
    Cabodi S; Tinnirello A; Bisaro B; Tornillo G; del Pilar Camacho-Leal M; Forni G; Cojoca R; Iezzi M; Amici A; Montani M; Eva A; Di Stefano P; Muthuswamy SK; Tarone G; Turco E; Defilippi P
    FASEB J; 2010 Oct; 24(10):3796-808. PubMed ID: 20505116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.
    Kang H; Kim C; Lee H; Rho JG; Seo JW; Nam JW; Song WK; Nam SW; Kim W; Lee EK
    Cell Death Differ; 2016 Mar; 23(3):484-95. PubMed ID: 26337669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids.
    Konstantinovsky S; Davidson B; Reich R
    Clin Exp Metastasis; 2012 Aug; 29(6):527-40. PubMed ID: 22476538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells.
    He XH; Zhu W; Yuan P; Jiang S; Li D; Zhang HW; Liu MF
    Oncogene; 2016 Nov; 35(46):6015-6025. PubMed ID: 27065318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
    Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ
    Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue.
    van der Flier S; van der Kwast TH; Claassen CJ; Timmermans M; Brinkman A; Henzen-Logmans SC; Foekens JA; Dorssers LC
    Int J Biol Markers; 2001; 16(3):172-8. PubMed ID: 11605729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ErbB2 and p38γ MAPK mediate alcohol-induced increase in breast cancer stem cells and metastasis.
    Xu M; Ren Z; Wang X; Comer A; Frank JA; Ke ZJ; Huang Y; Zhang Z; Shi X; Wang S; Luo J
    Mol Cancer; 2016 Jul; 15(1):52. PubMed ID: 27416801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells.
    Bisaro B; Montani M; Konstantinidou G; Marchini C; Pietrella L; Iezzi M; Galiè M; Orso F; Camporeale A; Colombo SM; Di Stefano P; Tornillo G; Camacho-Leal MP; Turco E; Taverna D; Cabodi S; Amici A; Defilippi P
    Breast Cancer Res; 2012 Oct; 14(5):R137. PubMed ID: 23098208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB2-enhanced invasiveness of H-Ras MCF10A breast cells requires MMP-13 and uPA upregulation via p38 MAPK signaling.
    Yong HY; Kim IY; Kim JS; Moon A
    Int J Oncol; 2010 Feb; 36(2):501-7. PubMed ID: 20043086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
    Xu FJ; Stack S; Boyer C; O'Briant K; Whitaker R; Mills GB; Yu YH; Bast RC
    Clin Cancer Res; 1997 Sep; 3(9):1629-34. PubMed ID: 9815853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
    Ma C; Lin H; Leonard SS; Shi X; Ye J; Luo J
    Oncogene; 2003 Aug; 22(34):5281-90. PubMed ID: 12917629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
    Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
    Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
    Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
    Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.